These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

721 related items for PubMed ID: 1282774

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
    Culine S, Théodore C, Bekradda M, Farhat F, Terrier-Lacombe MJ, Droz JP.
    Am J Clin Oncol; 1997 Apr; 20(2):184-8. PubMed ID: 9124197
    [Abstract] [Full Text] [Related]

  • 43. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M, Simon SD, de Góes GM.
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [Abstract] [Full Text] [Related]

  • 44. Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution.
    Germá JR, Sagarra AF, Izquierdo MA, Seguí MA.
    Cancer; 1993 Feb 01; 71(3):796-803. PubMed ID: 7679314
    [Abstract] [Full Text] [Related]

  • 45. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
    Vidal AD, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE.
    Ann Oncol; 2015 Feb 01; 26(2):374-7. PubMed ID: 25392157
    [Abstract] [Full Text] [Related]

  • 46. [Combined chemotherapy of the metastases of testicular teratoblastomas].
    Orel NF.
    Vopr Onkol; 1979 Feb 01; 25(4):25-30. PubMed ID: 86233
    [Abstract] [Full Text] [Related]

  • 47. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R, Stoter G, Kaye SB, Sleijfer DT, Jones WG, ten Bokkel Huinink WW, Rea LA, Collette L, Sylvester R.
    J Clin Oncol; 1997 May 01; 15(5):1837-43. PubMed ID: 9164193
    [Abstract] [Full Text] [Related]

  • 48. Reproductive toxicity with and without LHRHA administration during adjuvant chemotherapy in patients with germ cell tumors.
    Kreuser ED, Hetzel WD, Hautmann R, Pfeiffer EF.
    Horm Metab Res; 1990 Sep 01; 22(9):494-8. PubMed ID: 1701752
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
    Horwich A, Sleijfer DT, Fosså SD, Kaye SB, Oliver RT, Cullen MH, Mead GM, de Wit R, de Mulder PH, Dearnaley DP, Cook PA, Sylvester RJ, Stenning SP.
    J Clin Oncol; 1997 May 01; 15(5):1844-52. PubMed ID: 9164194
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ, Samson MK, Shah NT, Crawford ED, Ford CD, Altman SJ, Stephens RL, Natale RB, Bouroncle BA, Blumenstein BA.
    J Clin Oncol; 1991 Jan 01; 9(1):70-6. PubMed ID: 1702148
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Treatment of metastatic seminoma by chemotherapy.: an experience].
    Komatsubara S, Itoi T, Watanabe M, Kitamura Y, Koike T.
    Nihon Hinyokika Gakkai Zasshi; 2000 Jan 01; 91(10-11):666-72. PubMed ID: 11109817
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [AH-10/04 - international study on testicular cancer: randomized phase III study 1xBEP in comparison to 2xBEP for patients with non-seminomatous testicular cancer in clinical stage I (high risk)].
    Rexer H.
    Urologe A; 2011 Mar 01; 50(3):348-50. PubMed ID: 21327899
    [No Abstract] [Full Text] [Related]

  • 57. Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up.
    Dearnaley DP, Horwich A, A'Hern R, Nicholls J, Jay G, Hendry WF, Peckham MJ.
    Eur J Cancer; 1991 Mar 01; 27(6):684-91. PubMed ID: 1712606
    [Abstract] [Full Text] [Related]

  • 58. The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis.
    Cullen M, Huddart R, Joffe J, Gardiner D, Maynard L, Hutton P, Mazhar D, Shamash J, Wheater M, White J, Goubar A, Porta N, Witts S, Lewis R, Hall E, 111 Trial Management Group.
    Eur Urol; 2020 Mar 01; 77(3):344-351. PubMed ID: 31901440
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.